Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
Related Articles
-
bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy
bluebird bio, Inc. (Nasdaq: BLUE) announced today that it has completed the first commercial cell collection for LYFGENIA (lovotibeglogene autotemcel)
-
Older and Younger Cells Handle Genes Differently
In Aging Cell, researchers have published evidence that downregulating a key aspect of lipid metabolism harms mitochondrial function, but only in cells taken from younger people. Fat regulation at the cellular level Perilipins
-
How a stem cell transplant could help to stop epilepsy seizures
More than 630,000 people in the UK have epilepsy and, as a result of sudden bursts of electrical activity in their brain, experience seizures.